C RUSSELL III TRENARY Insider Profile
11 Followers
C RUSSELL III TRENARY, CEO & President, Director at Outlook Therapeutics, holds 54.92K shares in Outlook Therapeutics (Ticker: OTLK). Most recently, C RUSSELL III TRENARY Bought 19,925 shares of Outlook Therapeutics on Jun 23, 2022 for an estimated value of $21.12K.
C RUSSELL III TRENARY's Trading History
| OTLKOutlook Therapeutics | Jun 23, 2022 | CEO & President, Director | Informative Buy | 21.12K | $21.75K | |
You May Also Like
C RUSSELL III TRENARY insider profile FAQ
What is the percentage of profitable transactions made by C RUSSELL III TRENARY?
The percentage of profitable transactions made by C RUSSELL III TRENARY is 33%.
What is the average return per transaction made by C RUSSELL III TRENARY?
The average return per transaction made by C RUSSELL III TRENARY is 7.30%.
What stocks does C RUSSELL III TRENARY hold?
C RUSSELL III TRENARY holds: OTLK stocks.
What was C RUSSELL III TRENARY’s latest transaction?
C RUSSELL III TRENARY’s latest transaction was an Informative Buy of $21.12K.
What was C RUSSELL III TRENARY's most profitable transaction?
C RUSSELL III TRENARY’s most profitable transaction was an Informative Buy of OTLK stock on June 23, 2022. The return on the trade was 69.90%.
What is C RUSSELL III TRENARY's role in Outlook Therapeutics?
C RUSSELL III TRENARY's role in Outlook Therapeutics is CEO & President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
